Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Verona Pharma Plc
| -103.41K |
$2.29 | -$237,197.27 | -3.56% | 2.8M |
Feb 1
| |||||||
Verona Pharma Plc
| -173.90K |
$1.74 | -$303,253.80 | -6.03% | 2.71M |
Nov 1
| |||||||
Verona Pharma Plc
| 200K |
—
|
—
| +11.00% | 2.02M |
Oct 20
| |||||||
Verona Pharma Plc
| -48.47K |
$2.52 | -$121,914.10 | -1.78% | 2.68M |
Aug 3 - Aug 7
| |||||||
Verona Pharma Plc
| -31.55K |
$2.64 | -$83,414.62 | -1.59% | 1.96M |
Aug 1 - Aug 2
| |||||||
Verona Pharma Plc
| 8.33K |
—
|
—
| +0.42% | 1.99M |
May 1
| |||||||
Verona Pharma Plc
| -80.38K |
$2.58 | -$207,040.54 | -3.90% | 1.98M |
May 1
| |||||||
Verona Pharma Plc
| 26.8K |
$2.59 | -$394,272.80 | +0.95% | 2.83M |
Jan 20 - Feb 1
| |||||||
Verona Pharma Plc
| -240.00K |
$2.69 | -$646,032.00 | -7.88% | 2.81M |
Nov 21 - Dec 22
| |||||||
Verona Pharma Plc
| 800K |
—
|
—
| +45.38% | 2.56M |
Sep 26
| |||||||
Verona Pharma Plc
| -79.90K |
$0.67 | -$53,730.06 | -4.34% | 1.76M |
Aug 1
| |||||||
Verona Pharma Plc
| -79.90K |
$0.52 | -$41,745.66 | -4.16% | 1.84M |
May 1
| |||||||
Verona Pharma Plc
| -79.90K |
$0.78 | -$62,023.26 | -3.99% | 1.92M |
Feb 1
| |||||||
Verona Pharma Plc
| -79.90K |
$0.64 | -$51,133.44 | -3.84% | 2M |
Nov 1
| |||||||
Verona Pharma Plc
| -319.60K |
$0.79 | -$250,886.00 | -11.07% | 2.57M |
Aug 1
| |||||||
Verona Pharma Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||